Publication | Open Access

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseLongitudinal Head-to-head Comparison18F-florbetapir PetNeurologyNeuroscienceBrain PathologyMedicineAnti-amyloid-β Monoclonal AntibodiesLewy Body Dementia